Wuhan Hiteck Biological Pharma Co.,Ltd (SHE:300683)
China
· Delayed Price · Currency is CNY 35.34
+0.09 (0.26%)
Apr 30, 2026, 3:12 PM CST
SHE:300683 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Market Capitalization | 4,614 | 3,630 | 3,121 | 4,727 | 4,322 | 7,273 | Upgrade
|
| Market Cap Growth | 45.18% | 16.32% | -33.98% | 9.35% | -40.56% | 72.12% | Upgrade
|
| Enterprise Value | 4,254 | 2,955 | 2,310 | 3,665 | 3,553 | 6,267 | Upgrade
|
| Last Close Price | 35.25 | 27.73 | 23.70 | 35.90 | 35.19 | 59.21 | Upgrade
|
| PE Ratio | - | - | - | - | - | 262.98 | Upgrade
|
| Forward PE | - | 21.83 | 21.83 | 21.83 | 21.83 | 21.83 | Upgrade
|
| PS Ratio | 8.48 | 6.70 | 4.81 | 7.85 | 6.28 | 11.83 | Upgrade
|
| PB Ratio | 2.15 | 1.67 | 1.29 | 1.89 | 1.85 | 3.10 | Upgrade
|
| P/TBV Ratio | 2.66 | 2.07 | 1.66 | 2.44 | 2.25 | 3.79 | Upgrade
|
| P/OCF Ratio | - | - | 137.55 | 889.42 | 81.51 | 601.62 | Upgrade
|
| EV/Sales Ratio | 7.82 | 5.46 | 3.56 | 6.09 | 5.16 | 10.20 | Upgrade
|
| EV/EBITDA Ratio | - | - | - | - | 203.04 | 279.54 | Upgrade
|
| Debt / Equity Ratio | 0.03 | 0.03 | 0.02 | 0.03 | 0.04 | 0.04 | Upgrade
|
| Debt / EBITDA Ratio | - | - | - | - | 4.12 | 3.64 | Upgrade
|
| Net Debt / Equity Ratio | -0.17 | -0.34 | -0.34 | -0.41 | -0.41 | -0.47 | Upgrade
|
| Net Debt / EBITDA Ratio | 12.89 | 26.72 | 28.40 | 14.48 | -54.50 | -49.06 | Upgrade
|
| Net Debt / FCF Ratio | 4.70 | 5.89 | 40.67 | 6.33 | 7.89 | 4.68 | Upgrade
|
| Asset Turnover | 0.20 | 0.20 | 0.22 | 0.21 | 0.26 | 0.25 | Upgrade
|
| Inventory Turnover | 3.40 | 3.24 | 3.37 | 3.11 | 3.74 | 3.75 | Upgrade
|
| Quick Ratio | 2.58 | 3.63 | 3.23 | 3.88 | 4.46 | 5.85 | Upgrade
|
| Current Ratio | 4.17 | 3.98 | 3.60 | 4.30 | 5.07 | 6.35 | Upgrade
|
| Return on Equity (ROE) | -10.78% | -10.28% | -3.01% | -5.31% | -0.34% | 1.48% | Upgrade
|
| Return on Assets (ROA) | -2.89% | -2.76% | -2.46% | -3.07% | -0.78% | -0.34% | Upgrade
|
| Return on Invested Capital (ROIC) | -7.75% | -8.11% | -7.61% | -9.79% | -2.57% | -1.34% | Upgrade
|
| Return on Capital Employed (ROCE) | -5.50% | -5.40% | -4.50% | -5.30% | -1.40% | -0.50% | Upgrade
|
| Earnings Yield | -5.21% | -6.37% | -2.22% | -2.56% | -0.33% | 0.38% | Upgrade
|
| FCF Yield | -1.70% | -3.50% | -0.65% | -3.43% | -2.80% | -3.23% | Upgrade
|
| Dividend Yield | 0.37% | - | 0.55% | - | - | - | Upgrade
|
| Payout Ratio | - | - | - | - | - | 0.22% | Upgrade
|
| Buyback Yield / Dilution | -0.24% | 0.14% | -0.71% | -1.86% | -19.91% | -2.00% | Upgrade
|
| Total Shareholder Return | 0.12% | 0.14% | -0.17% | -1.86% | -19.91% | -2.00% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.